Sun Pharmaceutical Industries Limited (together with its subsidiaries and/or its associated companies, Sun Pharma) and Concert Pharmaceuticals, Inc. (Concert) announced that they have entered into a definitive agreement pursuant to which Sun Pharma will acquire all of the outstanding shares of Concert by way of a tender offer for an initial cash payment of 8.00…